Clinical Trial Update: PegIntron Injection Surveillance Plan (Study P04123)

View source ↗

Summary

A completed clinical trial update for the PegIntron injection surveillance plan (Study P04123) sponsored by Merck Sharp & Dohme LLC, involving Hepatitis C, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic | Status: COMPLETED | Results posted: 2010-12-13